Back
Fennec Pharmaceuticals, Inc. Vs. BlueLinx Holdings, Inc. Industry Stock Comparison
Sell
25
FRX.TO
Fennec Pharmaceuticals, Inc.
Last Price:
$10.63
Seasonality Move:
17.23%
Buy
56
BXC
BlueLinx Holdings, Inc.
Last Price:
$62.39
Seasonality Move:
23.8%
Sell
25
Fennec Pharmaceuticals, Inc. (FRX.TO)
is a Sell
Is Fennec Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Fennec Pharmaceuticals, Inc. [FRX.TO] share price is $10.63. The Score for FRX.TO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
FRX.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
BlueLinx Holdings, Inc. (BXC)
is a Buy
Is BlueLinx Holdings, Inc. a Buy, Sell or Hold?
-
The current BlueLinx Holdings, Inc. [BXC] share price is $62.46. The Score for BXC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FRX.TO Stock Price Chart
What is Fennec Pharmaceuticals, Inc.'s stock price today?
-
The Fennec Pharmaceuticals, Inc. share price today is $10.63Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FRX.TO is experiencing slight buying pressure.
BXC Stock Price Chart
What is BlueLinx Holdings, Inc.'s stock price today?
-
The BlueLinx Holdings, Inc. share price today is $62.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BXC is experiencing buying pressure, which is a positive indicator for future bullish movement.
FRX.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 42.68 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.37 - 11.33) | Sell |
| Bollinger Bands (100): | (10.93 - 12.55) | Sell |
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 50.05 | Buy |
| Chaikin Money Flow: | 22434 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.59 - 64.53) | Buy |
| Bollinger Bands (100): | (61.75 - 78.81) | Sell |
FRX.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.51 | Buy |
| 20-day SMA: | 10.68 | Sell |
| 50-day SMA: | 11.28 | Sell |
| 200-day SMA: | 10.85 | Sell |
| 8-day EMA: | 10.55 | Buy |
| 20-day EMA: | 10.73 | Sell |
| 50-day EMA: | 11.17 | Sell |
| 200-day EMA: | 10.95 | Sell |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.36 | Sell |
| 20-day SMA: | 62.54 | Sell |
| 50-day SMA: | 63.45 | Sell |
| 200-day SMA: | 71.99 | Sell |
| 8-day EMA: | 62.78 | Sell |
| 20-day EMA: | 62.4 | Buy |
| 50-day EMA: | 64.18 | Sell |
| 200-day EMA: | 74.48 | Sell |
Fennec Pharmaceuticals, Inc. Earnings Growth & FRX.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $1.25 per share.
BlueLinx Holdings, Inc. Earnings Growth & BXC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.29 per share, and an increase next year of $0.86 per share.
Fennec Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BlueLinx Holdings, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||